PARKE-DAVIS FDA Approval ANDA 080258

ANDA 080258

PARKE-DAVIS

FDA Drug Application

Application #080258

Documents

Label2009-10-19
Label2014-01-22
Label2014-01-22

Application Sponsors

ANDA 080258PARKE-DAVIS

Marketing Status

Prescription001

Application Products

001SYRUP;ORAL250MG/5ML0ZARONTINETHOSUXIMIDE

FDA Submissions

ORIG1AP1974-02-13
MANUF (CMC); Manufacturing (CMC)SUPPL12AP1995-07-28
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1996-03-13
MANUF (CMC); Manufacturing (CMC)SUPPL14AP1997-10-22
MANUF (CMC); Manufacturing (CMC)SUPPL16AP1998-10-27
LABELING; LabelingSUPPL20AP2006-10-03
LABELING; LabelingSUPPL25AP2009-05-06
LABELING; LabelingSUPPL26AP2009-11-20
LABELING; LabelingSUPPL27AP2009-11-20
REMS; REMSSUPPL28AP2011-04-25
LABELING; LabelingSUPPL29AP2014-01-16STANDARD
REMS; REMSSUPPL30AP2012-10-25
LABELING; LabelingSUPPL31AP2014-01-16STANDARD
LABELING; LabelingSUPPL32AP2021-10-29STANDARD
LABELING; LabelingSUPPL35AP2021-10-29STANDARD

Submissions Property Types

SUPPL12Null0
SUPPL13Null0
SUPPL14Null0
SUPPL16Null0
SUPPL25Null7
SUPPL26Null7
SUPPL27Null7
SUPPL29Null15
SUPPL30Null17
SUPPL31Null31
SUPPL32Null7
SUPPL35Null7

TE Codes

001PrescriptionAA

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 80258
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.